8-K: Sunshine Biopharma Appoints New Auditor M&K CPAS

Sunshine Biopharma Inc. has dismissed Bush & Associates CPA LLC and appointed M&K CPAS, PLLC as its new independent registered public accounting firm, effective September 24, 2025.

Summary

• Sunshine Biopharma Inc. (SBFM) changed its independent registered public accounting firm.
• Bush & Associates CPA LLC was dismissed, and M&K CPAS, PLLC was retained.
• The change was effective September 24, 2025.
• The Board of Directors and Audit Committee unanimously approved the decision.
• No disagreements on accounting principles, financial statement disclosure, or auditing scope were reported with Bush & Associates during fiscal years 2023, 2024, and the subsequent interim period through September 24, 2025.
• No reportable events, as defined in Item 304(a)(1)(v) of Regulation S-K, occurred.
• Audit reports from Bush & Associates for 2023 and 2024 did not contain adverse opinions, disclaimers, qualifications, or modifications.
• Neither the Company nor anyone on its behalf consulted with M&K regarding accounting principles or audit opinions prior to their retention.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an auditor change can sometimes signal issues, the explicit statements of no disagreements, no reportable events, and clean audit opinions for prior years mitigate any potential negative interpretations. The unanimous board and audit committee approval also reflects sound corporate governance.

Positives

• The change in auditor was approved unanimously by the Board of Directors and Audit Committee, indicating strong corporate governance.
• No disagreements on accounting principles or practices were reported with the outgoing auditor, Bush & Associates.
• No reportable events were identified during the fiscal years 2023, 2024, and the subsequent interim period.
• Audit reports for 2023 and 2024 from Bush & Associates were clean, without adverse opinions, disclaimers, qualifications, or modifications.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

Changes in independent registered public accounting firms are a routine corporate governance matter for publicly traded companies. Such changes can occur for various reasons, including fee negotiations, desire for a larger firm, or rotation policies. The explicit statement of no disagreements or reportable events with the outgoing auditor is a positive indicator, suggesting the change is not due to underlying financial reporting issues, which aligns with best practices for transparent auditor transitions.

Corporate Governance

Stakeholder Impact

• Shareholders: The change is presented as a routine matter with no reported disagreements, which should reassure investors about the integrity of financial reporting.
• Regulatory Authorities: The transparent disclosure of the auditor change, including the lack of disagreements, aligns with SEC requirements and expectations.

Next Steps

• Sunshine Biopharma Inc. will file an amendment to this report upon receipt of a letter from Bush & Associates CPA LLC, stating whether they agree with the disclosures made in this Form 8-K.

Key Dates

Recommendation

This filing details a routine change in the company's independent registered public accounting firm. The explicit statements that there were no disagreements with the outgoing auditor and no reportable events, coupled with clean audit opinions for prior years, suggest this is a standard corporate governance action rather than an indicator of underlying financial issues. As such, this specific filing does not provide new information that would significantly alter the investment thesis for Sunshine Biopharma Inc., warranting a 'hold' recommendation based solely on this report.

Keywords

Sunshine Biopharma, SBFM, Auditor Change, SEC Filing, Form 8-K, Public Accounting Firm, Corporate Governance, Financial Reporting, M&K CPAS, Bush & Associates